Apr 27,2022

Roche Diabetes Care and Fitterfly Partner to Improve Outcomes

Roche Diabetes Care India (RDC) and Fitterfly Healthtech, India's leading Digital Therapeutics (DTx) company have partnered to co-create a 90-day diabetes management programme for people with type 2 diabetes. The program is designed to give instant insights on blood sugar, in-depth assessments and personalised plans for nutrition, fitness and wellness to provide best-in-class outcomes. This is best suited for individuals with newly diagnosed type 2 diabetes, new and fast-changing prescriptions on insulin or those who have spotted new symptoms indicating long-term complications of diabetes.

COLLABORATION PARTNERSHIP

#r&d

#dtx

View Analyst & Ambassador Comments
Go to original news
Feb 14,2019

Senseonics Announces Partnership with Geo-Med to Provide Veterans Access to Eversense CGM

Senseonics Holdings today has announced that it has partnered with Geo-Med, LLC, a verified Service-Disabled Veteran-Owned Small Business (SDVOSB) to provide access to Eversense CGM to more than 9 million covered veterans and U.S. government personnel.

COLLABORATION COLLABORATION

#product & service

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 14,2019

Senseonics Announces a Positive Coverage Decision for Eversense CGM from Health Care Service Corporation

Senseonics Holdings announced that Health Care Service Corporation (HCSC) - Blue Cross Blue Shield is now providing coverage for the Eversense CGM System, effective October 15, 2019. Health Care Service Corporation, a Mutual Legal Reserve Company (HCSC), and an Independent Licensee of the Blue Cross and Blue Shield Association, is the fourth largest health insurer in the United States, operating as Blue Cross and Blue Shield Plans in Illinois, Montana, New Mexico, Oklahoma and Texas. 

COLLABORATION COLLABORATION

#insurance

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 18,2020

Senseonics Announces a Positive Coverage Decision for Eversense CGM from Cigna

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that Cigna is now providing coverage for the Eversense® CGM System, effective February 15, 2020. This most recent coverage decision – in addition to Aetna, Humana, HCSC Blue Cross Blue Shield and other health insurance providers – adds to the growing list of payers enabling their members to benefit clinically from the long-term Eversense CGM System.

COLLABORATION PARTNERSHIP

#insurance

#cgm

View Analyst & Ambassador Comments
Go to original news
Aug 07,2020

Senseonics Announces Positive Coverage Decision for Eversense CGM from Highmark Inc.

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced Highmark Inc. will begin providing coverage for the Eversense CGM effective September 28, 2020. Highmark is among the top 10 largest health insurers in the United States, providing plans to residents across Pennsylvania, West Virginia and Delaware as an independent licensee of the Blue Cross Blue Shield Association. The organization provides plans to over 5.6 million members and is the largest healthcare insurer in Pennsylvania and the fourth-largest overall Blue Cross Blue Shield affiliate.

COLLABORATION PARTNERSHIP

#insurance

View Analyst & Ambassador Comments
Go to original news
Jan 19,2021

Senseonics Announces a Positive Coverage Decision for Eversense CGM from EmblemHealth

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, announced today that EmblemHealth is now providing coverage for the Eversense® CGM System, effective immediately. EmblemHealth of New York, New Jersey and Connecticut has added coverage for Eversense in their 2021 CGM policy which expands access to approximately 2.9 million residents of these three states.

COLLABORATION PARTNERSHIP

#insurance

#cgm

View Analyst & Ambassador Comments
Go to original news
Apr 25,2018

Roche advances its open diabetes management ecosystem by integrating CGM data from Sensonics

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has signed a non-exclusive data integration agreement with Senseonics Incorporated, expanding its partnership. Under the terms of the agreement, both partners aim to implement the next step in data integration of the long-term Eversense Continuous Glucose Monitoring (CGM) system with Roche's suite of digital diabetes management solutions. This integration will allow for the real-time CGM data to be synchronised so Eversense users and their physicians will be able to review glucose values as well as related data online and on their mobile phones e.g. via the mySugr app or Accu-Chek Smart Pix. The initial data integration is planned to be available to users beginning 2019.

COLLABORATION PARTNERSHIP

#connected device

#cgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 10,2018

Medtronic Receives Health Canada Licence For The First Insulin Pump System That Automatically Adjusts Basal Insulin For People Living with Type 1 Diabetes

Medtronic of Canada Ltd., a subsidiary of Medtronic plc (NYSE: MDT), today announced it has received a licence from Health Canada for the MiniMed™ 670G system — the first insulin pump system in Canada that helps to stabilize glucose levels 24 hours a day by automatically adjusting basal insulin delivery based on real-time insulin needs. The MiniMed 670G system combines the company's most advanced SmartGuard™ algorithm and most accurate2 continuous glucose monitor (CGM), the Guardian™ Sensor 3, to provide simplified diabetes management for Canadians seven years of age and older living with type 1 diabetes.

PRODUCT

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
May 03,2016

UnitedHealthcare Chooses Medtronic as Preferred Insulin Pump Provider, Starting July 1

Insurance company UnitedHealthcare has chosen Medtronic as its preferred insulin pump supplier, starting July 1, 2016. The policy does not apply to children 18 years and younger, or to United Sierra Health, Life Commercial, and Medicare Advantage plans.

COLLABORATION PARTNERSHIP

#insurance

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Dec 08,2020

Medtronic Receives Health Canada Licence for MiniMed™ 770g Insulin Pump System with Smartphone Connectivity for People with Type 1 Diabetes

Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) – the world's largest medical technology, services, and solutions company – has received a licence from Health Canada for its MiniMed™ 770G insulin pump system. This is currently the only insulin pump system in Canada offering hybrid closed loop technology, with the added benefits of smartphone connectivity and an expanded age indication to children as young as two years.

PRODUCT

#insulin pump

#closed loop

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES